Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Mixed Methods Approach to Evaluating How Art Therapy Can Benefit Women Recently Diagnosed With Breast Cancer

NCT01220960 is registered in ClinicalTrials.gov with Dr. Sarkis Meterissian as lead sponsor.

NCT NCT01220960
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01220960 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Mixed Methods Approach to Evaluating How Art Therapy Can Benefit Women Recently Diagnosed With Breast Cancer
Lead sponsor
Dr. Sarkis Meterissian
Phase
Not applicable
Overall status
Completed
Start date
August 31, 2010
Completion date
October 31, 2013
Enrollment
64 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer